ReviewPharmaceuticals (Basel, Switzerland)2022

Targeting the DNA Damage Response Machinery for Lung Cancer Treatment.

Katharigatta N VenugopalaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.